Corrigendum to "One or two doses of live varicella virus-containing vaccines: Efficacy, persistence of immune responses, and safety six years after administration in healthy children during their second year of life" [Vaccine 36 (2018) 381-387]

Affiliations

• ¹ Vaccine Discovery and Development, GSK, Philadelphia, United States. Electronic address: ouzama.n.henry@gsk.com.
• ² Poradnia Chorób Zakaźnych ZOZ Dębica, Dębica, Poland. Electronic address: jerzy_br@poczta.onet.pl.
• ³ Infectious Diseases Outpatient Clinic, The St. Luis Provincial Specialist Children's Hospital, Cracow, Poland. Electronic address: hanna.czajka@onet.pl.
• ⁴ Pediatric Clinic, Lithuanian University of Health Sciences, Kaunas, Lithuania. Electronic address: giedralev@gmail.com.
• ⁵ Pharmacology, Saratov Medical University, Saratov, Russia. Electronic address: reshetko@yandex.ru.
• ⁶ Department of Health Sciences, Genoa University, Genoa, Italy. Electronic address: gasparini@unige.it.
• ⁷ Department of Epidemiology, Medical Faculty Pilsen of Charles University, Czech Republic. Electronic address: PAZDIORA@fnplzen.cz.
• ⁸ Pediatrics, University of Medicine and Pharmacy, Bucharest, Romania. Electronic address: doinaplesca@yahoo.com.
• ⁹ Servizio di Igiene Pubblica, ASL Sassari, Italy. Electronic address: madesole@aslsassari.it.
• ¹⁰ Pediatric Clinic, Lithuanian University of Health Sciences, Kaunas, Lithuania. Electronic address: rimantas.kevalas@kaunoklinikos.lt.
• ¹¹ Department of Medical Sciences, University of Ferrara, Ferrara, Italy. Electronic address: giovanni.gabutti@unife.it.
• ¹² Biostatistics, GSK, Wavre, Belgium. Electronic address: michael.x.povey@gsk.com.
• ¹³ Vaccine Discovery and Development, GSK, Philadelphia, United States. Electronic address: innisb00@gmail.com.